Announcement of Participation of NCI on PAR-07-416, Developmental Pharmacology (R01)

Notice Number: NOT-CA-08-009

Key Dates
Release Date: December 28, 2007

Issued by
National Cancer Institute (NCI) (www.cancer.gov)

Purpose

This Notice is to inform applicants that the National Cancer Institute (NCI) is participating in funding opportunity announcement PAR-07-416, entitled “Developmental Pharmacology (R01).”

The following Institutes continue to participate in PAR-07-416:

National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov)
National Institute of General Medical Sciences (NIGMS) (http://www.nigms.nih.gov)
National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov)
National Institute on Drug Abuse (NIDA) (http://www.nichd.nih.gov)
National Institute of Environmental Health Sciences (NIEHS) (http:/www.niehs.nih.gov)

Inquiries


For scientific/research inquiries to the NCI, contact:

William C. Timmer, Ph.D.
Clinical Grants and Contracts Branch
Cancer Therapy Evaluation Program
Division of Cancer Therapy and Diagnosis
National Cancer Institute
National Institutes of Health
6130 Executive Boulevard, EPN Room 7009, MSC 7432
Bethesda, MD 20892-7432 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)
Main Office Telephone: (301) 496-8866
Direct Telephone: (301) 594-9796
Fax: (301) 480-4663
E-mail: timmerw@mail.nih.gov

 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.